What is the address of JN MED?

The registered office of JN MED is located at Lambermontlaan 456, 1030 Schaarbeek.

Is JN MED still active?

Yes. According to the CBE (15 September 2026) JN MED is active, legal situation “Normale toestand”, started on 9 March 2005.

Is JN MED registered on Peppol?

Yes, JN MED is registered on the Peppol network with ID 0208:0872371280.

What is the enterprise number of JN MED?

The enterprise number of JN MED is BE0872371280.

When was JN MED founded?

JN MED was founded on 9 March 2005.

Who are the directors of JN MED?

According to the 2025 annual accounts, the directors of JN MED are: Zafer EL HUSSEINI.

Is JN MED a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 9 March 2005; 6 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did JN MED make in 2025?

JN MED posted a profit after taxes of € 176,944 in financial year 2025.

What is the revenue of JN MED?

As a small company, JN MED is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 278,377.

JN MED (Private Limited) - Schaarbeek - BE0872371280

Dossier JN MED, printed on 15 September 2026 from databakkes.be/en/0872371280/jn-med. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

JN MED from Schaarbeek, company number BE0872371280, closed financial year 2025 with a result of € 176,944 after tax. For that financial year JN MED recorded a gross margin of € 278,377 and equity of € 633,313. Compared with financial year 2024, the result moved from € 172,900 to € 176,944. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.

What it is worth Growing

€ 633,313

▲ 28% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 176,944

▲ 2% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 217,533

▼ 33% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 40,000 paid out

23 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 87,126

▲ 90% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 31,189

▼ 42% vs 2024

€ 7,798 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 3,374

▼ 58% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 115,500

▲ 154% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 102,018 Gross margin 2022: € 102,018 First fiscal year in the series	€ 117,488 Gross margin 2023: € 117,488 ▲ 15% vs 2022 (€ 102,018) Favourable step	€ 254,816 Gross margin 2024: € 254,816 ▲ 117% vs 2023 (€ 117,488) Favourable step	€ 278,377 Gross margin 2025: € 278,377 ▲ 9% vs 2024 (€ 254,816) Favourable step	▲ 9%
Profit after taxes	€ 52,740 Profit after taxes 2022: € 52,740 First fiscal year in the series	€ 67,894 Profit after taxes 2023: € 67,894 ▲ 29% vs 2022 (€ 52,740) Favourable step	€ 172,900 Profit after taxes 2024: € 172,900 ▲ 155% vs 2023 (€ 67,894) Favourable step	€ 176,944 Profit after taxes 2025: € 176,944 ▲ 2% vs 2024 (€ 172,900) Favourable step	▲ 2%
Equity	€ 255,575 Equity 2022: € 255,575 First fiscal year in the series	€ 323,469 Equity 2023: € 323,469 ▲ 27% vs 2022 (€ 255,575) Favourable step	€ 496,369 Equity 2024: € 496,369 ▲ 53% vs 2023 (€ 323,469) Favourable step	€ 633,313 Equity 2025: € 633,313 ▲ 28% vs 2024 (€ 496,369) Favourable step	▲ 28%
Total debts	€ 103,728 Total debts 2022: € 103,728 First fiscal year in the series	€ 65,763 Total debts 2023: € 65,763 ▼ 37% vs 2022 (€ 103,728) Favourable step	€ 108,992 Total debts 2024: € 108,992 ▲ 66% vs 2023 (€ 65,763) Unfavourable step	€ 191,151 Total debts 2025: € 191,151 ▲ 75% vs 2024 (€ 108,992) Unfavourable step	▲ 75%
Cash	€ 104,592 Cash 2022: € 104,592 First fiscal year in the series	€ 172,016 Cash 2023: € 172,016 ▲ 64% vs 2022 (€ 104,592) Favourable step	€ 324,330 Cash 2024: € 324,330 ▲ 89% vs 2023 (€ 172,016) Favourable step	€ 217,533 Cash 2025: € 217,533 ▼ 33% vs 2024 (€ 324,330) Unfavourable step	▼ 33%
Land & buildings	€ 40,796 Land & buildings 2022: € 40,796 First fiscal year in the series	€ 20,843 Land & buildings 2023: € 20,843 ▼ 49% vs 2022 (€ 40,796) Unchanged	€ 5,816 Land & buildings 2024: € 5,816 ▼ 72% vs 2023 (€ 20,843) Unchanged	€ 5,788 Land & buildings 2025: € 5,788 Unchanged (€ 5,816) Unchanged
Retained profit	€ 243,075 Retained profit 2022: € 243,075 First fiscal year in the series	€ 310,969 Retained profit 2023: € 310,969 ▲ 28% vs 2022 (€ 243,075) Favourable step	€ 483,869 Retained profit 2024: € 483,869 ▲ 56% vs 2023 (€ 310,969) Favourable step	€ 620,813 Retained profit 2025: € 620,813 ▲ 28% vs 2024 (€ 483,869) Favourable step	▲ 28%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 40,000 Dividend 2025: € 40,000 Unchanged (€ 0) Unchanged
Bank debt	€ 95,402 Bank debt 2022: € 95,402 First fiscal year in the series	€ 56,854 Bank debt 2023: € 56,854 ▼ 40% vs 2022 (€ 95,402) Favourable step	€ 53,876 Bank debt 2024: € 53,876 ▼ 5% vs 2023 (€ 56,854) Favourable step	€ 31,189 Bank debt 2025: € 31,189 ▼ 42% vs 2024 (€ 53,876) Favourable step	▼ 42%
Balance sheet total	€ 359,303 Balance sheet total 2022: € 359,303 First fiscal year in the series	€ 389,232 Balance sheet total 2023: € 389,232 ▲ 8% vs 2022 (€ 359,303) Unchanged	€ 605,361 Balance sheet total 2024: € 605,361 ▲ 56% vs 2023 (€ 389,232) Unchanged	€ 824,464 Balance sheet total 2025: € 824,464 ▲ 36% vs 2024 (€ 605,361) Unchanged	▲ 36%

Key figures of JN MED, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to JN MED?

What happened at JN MED in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 31, 2026 New annual accounts for financial year 2025: profit of € 176,944 (▲ 2% vs 2024). filed late Source: NBB ↗
2023 Zafer EL HUSSEINI became a director. NBB
Mar 9, 2005 Start of the company according to the CBE. KBO

In short

From € 52,740 profit in 2022 to € 176,944 profit in 2025.

Paid € 182,761 in corporate taxes since 2022.

Best year ever: 2025, with € 176,944 profit.

Paid out € 40,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at JN MED? We notify you, reason included.

Follow JN MED

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Zafer EL HUSSEINI

JN MED

Behind JN MED is Zafer EL HUSSEINI.

See the full network in the app

Directors

According to the 2025 annual accounts

Zafer EL HUSSEINI

Manager

since 2023

Establishments

Establishment units

Physical locations of this company

Registered office

Lambermontlaan 456

1030 Schaarbeek

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

J.S.Stevens

HOWARD TENENS

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0872.371.280
VAT number: BE 0872.371.280
Registered office: Lambermontlaan 456, 1030 Schaarbeek
Names & denominations: JN MED
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 9 March 2005
Peppol: Active · Active since 8 Jan 2026

View on CBE Public ↗ Annual accounts (NBB) ↗